Completed NA INTERVENTIONAL 2-arm NCT03147807

BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU (BLUE-CarbA)

BetaLACTA® Test-guided Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections Diagnosed in Intensive Care Unit - BLUE¬-CarbA Study

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Bloodstream Infection Pneumonia Urinary Tract Infections

Interventions betaLACTA® rapid diagnostic test

Updated 8 times since 2017 Last updated: Dec 16, 2022 Started: Oct 20, 2017 Primary completion: Sep 21, 2019 Completion: Oct 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bloodstream Infection and Pneumonia and is currently completed. Assistance Publique - Hôpitaux de Paris leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Jan 2023 [monthly]

Unknown Status NA
Feb 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Feb 2020 [monthly]

Recruiting NA
Mar 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2017 — Mar 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France